MET and neoplasm: In a third of patients assessed for MET expression analysis, there was a lack of agreement in dichotomised low and high groups representing MET RNA‐ISH and c‐MET IHC protein expression, with nonconcordance demonstrated in 27.91% of tumours assessed.